Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 8793
MIM: 603614
HGNC: 11907
Ensembl: ENSG00000173530
Variants:
dbSNP: 8793
ClinVar: 8793
TCGA: ENSG00000173530
COSMIC: TNFRSF10D
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000173530 | ENST00000312584 | Q9UBN6 |
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 31612990 | 2020 | Survival of aging CD264(+) and CD264(-) populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency. | 7 |
| 31612990 | 2020 | Survival of aging CD264(+) and CD264(-) populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency. | 7 |
| 31183506 | 2019 | Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients. | 8 |
| 31183506 | 2019 | Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients. | 8 |
| 29879421 | 2018 | High-dose HOOK effect in urinary DcR2 assay in patients with chronic kidney disease. | 1 |
| 29879421 | 2018 | High-dose HOOK effect in urinary DcR2 assay in patients with chronic kidney disease. | 1 |
| 28356293 | 2017 | Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy. | 7 |
| 28962588 | 2017 | Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells. | 20 |
| 28356293 | 2017 | Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy. | 7 |
| 28962588 | 2017 | Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells. | 20 |
| 26050621 | 2016 | Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity. | 32 |
| 26542757 | 2016 | Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer. | 11 |
| 26050621 | 2016 | Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity. | 32 |
| 26542757 | 2016 | Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer. | 11 |
| 24649804 | 2014 | Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer. | 0 |
Citation
Dessen P
TNFRSF10D (TNF receptor superfamily member 10d)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/42608/tnfrsf10d
